MedTrace Logo

Single Site, Masked, Randomized, Controlled Study to Assess Efficacy of Osurdex as Adjunct to Avastin Compared With Avastin Alone in the Treatment of Patients With Macular Edema Due to Central or Branch Retinal Vein Occlusion

NCT01085734 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2014-04-21

Study results available
· View outcomes & findings →

Summary

Comparative study to see if treating with Osurdex in addition to Avastin in patients with retinal vein occlusions helps increased visual acuity outcomes

Conditions

  • Retinal Vein Occlusions

Interventions

DRUG

Avastin

1.25mg intravitreally

DRUG

Osurdex

0.7mg intravitreally

DRUG

Avastin

1.25mg intravitreally

Sponsors & Collaborators

  • Maturi, Raj K., M.D., P.C.

    lead INDIV

Principal Investigators

  • Raj K Maturi, MD · Raj K. Maturi, MD, PC

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-03-31
Primary Completion
2011-10-31
Completion
2011-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01085734 on ClinicalTrials.gov